Efficacy and Safety of Frontline Treatment Options for ALK+ NSCLC
November 30th 2021Karen Reckamp, MD, and Jyoti Patel, MD, review currently available frontline treatment options for ALK+ advanced NSCLC and discuss updated efficacy and safety data from key clinical trials of these agents in advanced NSCLC.
Watch
The Potential of Rebastinib in Platinum-Resistant Ovarian Cancer Treatment
November 29th 2021Erika Hamilton, MD, discusses the mechanism of action of rebastinib, which is currently being explored in combination with weekly paclitaxel 1b/2 study of patients with platinum-resistant ovarian cancer.
Watch
Treating Metastatic Cholangiocarcinoma
November 24th 2021An overview of the standard of care for patients with metastatic cholangiocarcinoma, and the significance of conducting clinical trials that increase the number and types of therapies available to patients with fewer adverse events and better results.
Watch